Bicycle: ‘Maintain’ On Zelenectide Deprioritization And Shift To EphA2+ Tumor Concentrating onTerry ChrisomalisAugust 4, 20260 The last time I wrote about Bicycle Therapeutics (BCYC) it was with a Seeking Alpha article entitled “Bicycle: 2nd Half Of 2024 Data Could Provide Significant Inflection Point.” With respect to this Read More